Company
Abliva
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
A Swedish drug development company focused on treatments for rare primary mitochondrial diseases. Acquired by Pharming in 2025.
About the company
- Status notes
- Acquired by Pharming in 2025.
Exit
- Acquisition
- 2025
Loading relationship preview